Small Molecules
17 April 2014
Agios Initiates Phase 1 Study of AG-348, a First-in-class PKR Activator, for Pyruvate Kinase Deficiency17 April 2014
Islet Sciences Announces Positive 12-Week Phase 2 Clinical Results for SGLT2 Inhibitor Remogliflozin Etabonate15 April 2014
PanOptica Raises $45 Million to Finance Clinical Development of Anti-VEGF Eye Drop for Wet AMD15 April 2014
Akebia Therapeutics Announces Completion of Enrollment in its Phase 2b Clinical Study of AKB-654815 April 2014
Positive Results Of MuGard Study In Erosive Oral Lichen Planus Presented At International Oral Medicine Meeting14 April 2014
Study Shows Cellceutix Antibiotic Active Against Drug-Resistant Superbug Klebsiella Pneumoniae13 April 2014
Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session13 April 2014
Medivir: Final Data from the Phase II COSMOS Study with Simeprevir in Combination with Sofosbuvir Presented at EASL11 April 2014
Theravance Announces Initiation of Phase 2b Study With TD-4208, an Investigational LAMA for the Treatment of COPDNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports